Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -11.68 | 33.15 |
| PEG Ratio (TTM) | -0.58 | 11.22 |
| P/S Ratio (TTM) | 1.96 | 3.09 |
| P/B Ratio (TTM) | 1.48 | 7.21 |
| P/FCF Ratio (TTM) | -13.73 | 33.93 |
| Price to 5YR AVG Earnings Ratio | N/A | 78.36 |
| Price to 5YR AVG FCF Ratio | N/A | 604.51 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.88% | 8.30% |
| ROE (TTM) | -10.93% | 19.95% |
| Net Profit Margin (TTM) | -16.29% | 7.99% |
| ROIC 5YR AVG | N/A | 25.16% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.58% | -44,413.75% | N/A |
| Revenue | 1.56% | 4.79% | N/A |
| Net Income | 6.16% | -13.92% | N/A |
| Cash Flow | 9.53% | -160.24% | N/A |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.47 | 1.26 |
| Quick Ratio (TTM) | 4.47 | 1.04 |
| D/E Ratio (TTM) | 0.22 | 0.37 |
| Interest Coverage (TTM) | -2,735.38 | 0.03 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 0.32 | 4.87 |
| LTL to 5YR AVG FCF | N/A | 41.71 |
| Shares Outstanding Growth 5YR AVG | N/A | 6.88% |